Atm Deletion With Dual Recombinase Technology Preferentially Radiosensitizes Tumor Endothelium

Journal of Clinical Investigation - United States
doi 10.1172/jci73932
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Adenoviral Transduction of Human Acid Sphingomyelinase Into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure

PLoS ONE
Multidisciplinary
2013English

The Brain-Penetrant Clinical ATM Inhibitor AZD1390 Radiosensitizes and Improves Survival of Preclinical Brain Tumor Models

Science advances
Multidisciplinary
2018English

MK-8776, a Novel Chk1 Kinase Inhibitor, Radiosensitizes P53-Defective Human Tumor Cells

Oncotarget
Oncology
2016English

Paracrine Induction of Endothelium by Tumor Exosomes

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2009English

Tumor Suppressor Protein P53 Binds Preferentially to Supercoiled DNA

Oncogene
Cancer ResearchGeneticsMolecular Biology
1997English

A Survey on Human Computer Interaction Technology for ATM

International Journal of Intelligent Engineering and Systems
EngineeringComputer Science
2013English

Dual-Mode Routing: A Long Term Strategy for IP Over ATM

1997English

Mimicking the Endothelium: Dual Action Heparinized Nitric Oxide Releasing Surface

English

Breaking Up With ATM

Journal of Immunological Sciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy